Blair William & CO Vista Gen Therapeutics, Inc. Transaction History

Blair William & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.62 - $3.45 $31,964 - $42,090	-12,200 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$1.96 - $3.15 $23,912 - $38,430	12,200 New	12,200 $38,000
Q1 2020 May 11, 2020	SELL	$0.32 - $0.8 $16,371 - $40,928	-51,161 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$0.3 - $1.41 $415,303 - $1.95 Million	-1,384,344 Reduced 96.44%	51,161 $35,000
Q3 2019 Nov 12, 2019	BUY	$0.46 - $1.29 $660,332 - $1.85 Million	1,435,505 New	1,435,505 $1.54 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $645M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.